“Specialty Drugs”

57 result(s)
Specialty
The Impact of Autoimmune Conditions on Women
Women are overrepresented among autoimmune patients so may benefit the most from new biosimilar treatments More
Briefing
Specialty
Specialty Dermatologicals Spend Grows 168 Percent in 5 Years
Specialty Dermatologicals Continue to Be High Cost Drivers More
Briefing
Drug Pipeline
Promising Treatments for Alopecia Areata in the Pipeline
New Treatments for Alopecia Areata on the Horizon More
Briefing
Female caregiver and elderly patient discussing medical information on a couch
Specialty
Safer Options for Infusion Treatments
Research published by Coram shows that helping patients transition to at-home or ambulatory center infusion treatments can be beneficial to both patients and payors. More
Briefing
Icon of an infusion bag, overlaying a rising line graph
Specialty
Managing the MS Cost Challenge
Multiple Sclerosis is a $19 billion market worldwide, and the third most expensive specialty drug spend category. Recently approved Ocrevus is likely to add to cost of treatment... More
Briefing
Drug Pipeline
Keeping an Eye on the Drug Pipeline
New Drugs for Ophthalmic Disorders on the Horizon More
Briefing
Specialty
High-Touch, Whole Patient Care for PAH
PAH is a rare, life-threatening disease, which is incurable. It is difficult to manage and to help ensure the longest survival and best possible quality of life, members need... More
Briefing
Specialty
Multiple Specialty Vendors Mean More Headaches
Multiple Specialty Vendors Mean More Headaches More
Commentary
Specialty
Know the Risks of Specialty Carve-out
Know the Cost and Care Risks of Specialty Carve-out More
Video
Cost Management
Strategy and Balance: Managing Costs for Pulmonary Arterial Hypertension
Managing Treatment Costs for Pulmonary Arterial Hypertension More
Briefing